Laboratory of Jeffrey Martens uses gene therapy approaches to rescue olfactory loss in a pre-clinical model of congenital anosmia

“The major impact of this work is in demonstrating that viral-mediated gene therapy to restore odor detection extends to the rescue of odor-guided behaviors which is an important pre-clinical step for the future translation of gene therapy studies in the olfactory system to patients. It is a message of hope that future work will bring a viable therapy for patients with congenital olfactory loss that will improve their quality of life.” – Dr. Martens